Forgetting the little things can just be a symptom of a busy lifestyle. Everyone has memory lapses and it is not a cause for concern. But for some, it’s small lapses like these that may indicate a condition known as Mild Cognitive Impairment – one of the first signs of Alzheimer’s disease.
The Canterbury Geriatric Medical Research Trust (CGMRT) is trialling a new investigational medication that could help slow the progression of the disease. The Trust is one of six Australasian sites tackling early memory loss and is looking for people who may qualify for the clinical trial.
The line between every-day forgetfulness and early memory loss is extremely fine, so it can take a lot of work to find people who meet the criteria. Unlike many other clinical studies, this one is looking for people who may not even know they are unwell yet.